New Study Explores the Roots of Anxiety in Parkinson’s

A new research project, supported by a grant from The Michael J. Fox Foundation for Parkinson’s Research, is taking a closer look at why anxiety happens in Parkinson’s disease—and what can be done about it. 🔬 What’s the Focus? The study is investigating whether anxiety in Parkinson’s might be caused by the buildup of a protein called alpha-synuclein in the amygdala, a part of the brain involved in processing emotions like fear and anxiety. This protein is already known to play a key role in the development of Parkinson’s motor symptoms. 🧩 Why This Matters While Parkinson’s is often known for tremors and movement issues, nonmotor symptoms like anxiety can appear even before motor signs and can seriously affect quality of life. Yet, these emotional symptoms often get less attention and have fewer treatment options. 🤝 Who’s Behind the Research? The project brings together researchers from across the U.S., including: Dr. Christopher Bishop and Dr. Marvin Diaz at Binghamton University (New York) Dr. Fredric Manfredsson at the Barrow Neurological Institute (Arizona) Their collaboration combines expertise in brain connectivity and Parkinson’s disease mechanisms. 🧪 How Will They Study It? Using a preclinical model that mimics human Parkinson’s, the team will: Track the buildup of alpha-synuclein in the amygdala Observe anxiety-related behaviors (like reduced exploration in new environments) Investigate brain changes using biomarkers like cerebrospinal fluid Study whether affected brain cells can be treated, since they appear disrupted but not dead 🌱 Hope for the Future Preliminary findings show that anxiety symptoms can occur without neuron loss—meaning the affected brain cells might still be treatable. Understanding how anxiety develops in Parkinson’s could lead to: Earlier diagnosis More targeted treatments for nonmotor symptoms Improved quality of life for people living with Parkinson’s 🧡 The Bottom Line This study is a promising step toward understanding and addressing the emotional side of Parkinson’s. Anxiety in Parkinson’s is real, biological, and treatable—and research like this is helping shine a light on new ways to care for both brain and well-being.